| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 103.115 | 158.288 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 169.071 | 240.043 | 0 | 0 | 0 | 0 | 0 | 38.043 | 35.659 |
| Total Expenses - EUR | 13.023 | 140.718 | 231.538 | 7.830 | 727 | -240 | 1.652 | 2.145 | 35.741 | 33.301 |
| Gross Profit/Loss - EUR | -13.023 | 28.353 | 8.506 | -7.830 | -727 | 240 | -1.652 | -2.145 | 2.302 | 2.358 |
| Net Profit/Loss - EUR | -13.023 | 23.557 | 6.923 | -7.830 | -727 | 215 | -1.652 | -2.145 | 1.839 | 1.913 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diafil Imob Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 118.695 | 0 | 0 | 0 | 0 | 0 | 757 | 67.716 | 32.760 | 0 |
| Current Assets | 26.748 | 40.911 | 16.079 | 6.572 | 6.565 | 6.243 | 6.344 | 6.564 | 6.273 | 2.178 |
| Inventories | 2.331 | 51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 23.535 | 299 | 5.809 | 6.490 | 6.463 | 6.192 | 6.329 | 6.508 | 4.675 | 1.425 |
| Cash | 882 | 40.561 | 10.270 | 81 | 102 | 51 | 15 | 56 | 1.597 | 753 |
| Shareholders Funds | -12.987 | 10.703 | 6.975 | -983 | -1.691 | -1.444 | -3.064 | -5.218 | -4.836 | -2.896 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 158.430 | 30.408 | 9.104 | 7.555 | 8.256 | 7.686 | 10.165 | 79.498 | 43.869 | 5.074 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Diafil Imob Srl